These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21416609)

  • 1. Process analytical technology (PAT) for biopharmaceuticals.
    Glassey J; Gernaey KV; Clemens C; Schulz TW; Oliveira R; Striedner G; Mandenius CF
    Biotechnol J; 2011 Apr; 6(4):369-77. PubMed ID: 21416609
    [No Abstract]   [Full Text] [Related]  

  • 2. Uncorking the biomanufacturing bottleneck.
    Dove A
    Nat Biotechnol; 2002 Aug; 20(8):777-9. PubMed ID: 12148000
    [No Abstract]   [Full Text] [Related]  

  • 3. Defining process design space for monoclonal antibody cell culture.
    Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
    Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Yu M; Yeboah S; Sharma A
    Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioreactor systems for the production of biopharmaceuticals from animal cells.
    Warnock JN; Al-Rubeai M
    Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Latest methods and advances in biotechnology.
    Lee SY; Jungbauer A
    Biotechnol J; 2014 Jan; 9(1):2-4. PubMed ID: 24408606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process analytical technology (PAT) for biopharmaceutical products: Part II. Concepts and applications.
    Read EK; Shah RB; Riley BS; Park JT; Brorson KA; Rathore AS
    Biotechnol Bioeng; 2010 Feb; 105(2):285-95. PubMed ID: 19731253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level protein expression in scalable CHO transient transfection.
    Ye J; Kober V; Tellers M; Naji Z; Salmon P; Markusen JF
    Biotechnol Bioeng; 2009 Jun; 103(3):542-51. PubMed ID: 19199356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using partition designs to enhance purification process understanding.
    Pieracci J; Perry L; Conley L
    Biotechnol Bioeng; 2010 Dec; 107(5):814-24. PubMed ID: 20632374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roadmap for implementation of quality by design (QbD) for biotechnology products.
    Rathore AS
    Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic assessment of process analytical technologies for biologics.
    Gillespie C; Wasalathanthri DP; Ritz DB; Zhou G; Davis KA; Wucherpfennig T; Hazelwood N
    Biotechnol Bioeng; 2022 Feb; 119(2):423-434. PubMed ID: 34778948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of the 2A/furin technology with an animal component free cell line development platform process.
    Jostock T; Dragic Z; Fang J; Jooss K; Wilms B; Knopf HP
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1517-24. PubMed ID: 20461511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionation of follicle stimulating hormone charge isoforms in their native form by preparative electrophoresis technology.
    Catzel D; Chin DY; Stanton PG; Gray PP; Mahler SM
    J Biotechnol; 2006 Mar; 122(1):73-85. PubMed ID: 16198015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new use for existing technology - continuous precipitation for purification of recombination proteins.
    Warikoo V; Godawat R
    Biotechnol J; 2015 Aug; 10(8):1101-2. PubMed ID: 25781861
    [No Abstract]   [Full Text] [Related]  

  • 16. Modeling shear-induced CHO cell damage in a rotary positive displacement pump.
    Kamaraju H; Wetzel K; Kelly WJ
    Biotechnol Prog; 2010; 26(6):1606-15. PubMed ID: 20665469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
    Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
    Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process analytical technology (PAT) for biopharmaceutical products.
    Rathore AS; Bhambure R; Ghare V
    Anal Bioanal Chem; 2010 Sep; 398(1):137-54. PubMed ID: 20480150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells.
    Dreesen IA; Fussenegger M
    Biotechnol Bioeng; 2011 Apr; 108(4):853-66. PubMed ID: 21404259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid modeling for quality by design and PAT-benefits and challenges of applications in biopharmaceutical industry.
    von Stosch M; Davy S; Francois K; Galvanauskas V; Hamelink JM; Luebbert A; Mayer M; Oliveira R; O'Kennedy R; Rice P; Glassey J
    Biotechnol J; 2014 Jun; 9(6):719-26. PubMed ID: 24806479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.